PMV Pharmaceuticals, Inc.
- PMVP
- NASDAQ
- Biotechnology
- Precision Oncology
- p53-Mutation Targeted Therapies
$1.24
Today +2.57%Quote Oct 19, 2026, 01:55 PM UTC
−17.12%over the last month
Max drawdown −32.4%From 1-month high −32.4%3 months −5.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$66.2M
Quote Oct 19
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$5.00
+302.9% from here
Floor
$1.23
1.2% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PMVPPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
54
Founded
2013